By Matt Harrington, BCBA · Behaviorist Book Club · April 2026 · 12 min read

Navigating Funding Source Conflicts: Ethical Strategies for Behavior Analysts Working with Payers

Overview & Clinical Significance

The relationship between behavior analysts and funding sources, whether insurance companies, Medicaid, school districts, or other payers, is among the most consequential and least discussed aspects of clinical practice. When conflicts arise between what a payer authorizes and what a client needs, the behavior analyst occupies a position of significant ethical tension. They are simultaneously obligated to provide effective treatment to their client and dependent on the payer's approval to deliver that treatment.

This webinar on behavioral funding source engagement addresses the ethical complexities of this relationship with a focus on scalable solutions for handling conflict. The phrase "ethically scaled" in the course subtitle is particularly important because it acknowledges that these conflicts occur across all practice sizes and settings, from solo practitioners to large organizations, and that the strategies for navigating them must work at every scale.

Funding source conflicts take many forms. A payer may deny authorization for the number of hours the behavior analyst has determined to be clinically necessary. A payer may require the use of specific assessment tools or intervention approaches that the behavior analyst does not consider to be in the client's best interest. A payer may set documentation requirements that consume clinical time without contributing to treatment quality. A payer may terminate authorization when the behavior analyst's data show continued clinical need.

Each of these conflicts places the behavior analyst at a decision point where their ethical obligations may pull in different directions. The obligation to provide effective treatment argues for advocating aggressively for the client's needs. The practical reality of funding dependence argues for maintaining a cooperative relationship with the payer. The obligation to avoid abandoning a client argues against simply terminating services when funding is reduced. The obligation to practice within one's defined role argues for understanding the boundaries of what a behavior analyst can and should do in disputes with payers.

The clinical significance extends beyond individual cases. How behavior analysts collectively engage with funding sources shapes the field's ability to serve clients. When practitioners consistently accept inadequate authorizations without appeal, payers learn that these authorizations are sufficient. When practitioners engage in effective advocacy that changes payer behavior, the entire client population benefits from improved access to appropriate services.

Background & Context

The landscape of ABA funding has transformed dramatically over the past two decades. Insurance mandates for autism-related services, Medicaid coverage expansions, and growing recognition of ABA as an evidence-based treatment have dramatically increased the number of clients accessing services through third-party payers. This growth has brought enormous benefits in terms of access but has also created new categories of professional conflict that the field is still learning to navigate.

Historically, many ABA providers operated outside the insurance system, serving clients through school contracts, private pay, or research grants. The rules of engagement were relatively straightforward. The expansion of insurance-funded ABA services introduced a complex new set of stakeholders: utilization management companies, prior authorization reviewers, claims processors, and corporate policy makers who may have limited understanding of behavioral science but hold significant power over what services are delivered.

This webinar, originally presented through the Behavior Analysis Advocacy Network (BAAN) in 2018, reflects a period when the ABA field was actively grappling with these new dynamics. The challenges identified then have only intensified as the field has continued to grow and as payers have become more sophisticated in their management of ABA benefits.

The power asymmetry between individual behavior analysts and large payer organizations creates structural conditions that favor the payer in disputes. A payer that denies an authorization knows that the provider must either accept the denial, invest time and resources in an appeal, or risk losing the client. The behavior analyst, meanwhile, faces the immediate pressure of a client whose treatment is at stake. This asymmetry means that ethical engagement with funding sources is not just a matter of individual skill but of systemic advocacy and collective professional action.

The BAAN's focus on advocacy reflects an understanding that individual case-level conflicts are often symptoms of systemic issues: inadequate benefit structures, uninformed medical necessity criteria, and utilization management practices that prioritize cost containment over clinical outcomes. Addressing these systemic issues requires behavior analysts to develop skills in areas that extend beyond direct clinical practice: policy analysis, professional communication, appeals writing, and collaborative advocacy.

Clinical Implications

Conflicts with funding sources have direct and often immediate effects on clinical care. When an authorization is denied or reduced, the client may lose access to hours of service that the behavior analyst has determined to be clinically necessary. This reduction may affect not just the quantity of treatment but its quality: the behavior analyst may need to prioritize certain goals over others, reduce supervision intensity, or modify treatment protocols to fit within reduced hours.

The clinical implications of authorization reductions depend on where the client is in their treatment trajectory. For a client in the early stages of intensive intervention, a reduction from 25 to 15 authorized hours per week may eliminate the intensity needed to produce meaningful progress. For a client who has made significant gains and is transitioning toward less intensive support, a similar reduction may be clinically appropriate. The behavior analyst must be able to articulate these clinical distinctions in communications with payers.

Documentation quality is a critical clinical variable in funding source engagement. Authorization requests, progress reports, and treatment plans that clearly articulate the behavioral justification for the requested services are more likely to be approved and more defensible in appeals. This means that the behavior analyst's ability to translate behavioral data and clinical reasoning into language that payers understand is itself a clinical skill with direct implications for client access to treatment.

When payers require specific assessment tools or intervention approaches, the behavior analyst must evaluate whether complying serves the client's interest. In some cases, payer-required assessments may provide useful supplementary data. In other cases, they may be irrelevant to the client's treatment needs and consume session time that would be better spent on direct intervention. Navigating these requirements while maintaining clinical integrity requires diplomatic but firm advocacy.

The emotional and time costs of funding source conflicts also affect clinical practice. Behavior analysts who spend hours on authorization requests, appeals, and peer-to-peer reviews have less time available for direct clinical work. The frustration and burnout associated with repeated funding conflicts can affect practitioner well-being and, by extension, the quality of care they provide. Organizations that systematically support their clinicians in navigating funding conflicts, through dedicated authorization staff, appeal templates, and peer support, protect both their clinicians and their clients.

Clients and families experience funding source conflicts as uncertainty and stress. A family that receives a denial letter or a reduction in authorized hours may not understand the reasons or know their rights. Behavior analysts who can explain the process, set realistic expectations, and advocate effectively provide a level of support that extends beyond behavioral treatment.

Ethical Considerations

The BACB Ethics Code provides guidance for navigating funding source conflicts, though applying these standards in practice requires careful judgment.

Code 2.01 (Providing Effective Treatment) establishes the primary obligation: behavior analysts must provide and advocate for treatment that meets the client's clinical needs. When a funding source authorizes less treatment than what is clinically indicated, this standard creates an affirmative obligation to appeal the decision, provide additional documentation, and pursue all available avenues for obtaining appropriate authorization.

Code 2.04 (Explaining Assessment Results) requires behavior analysts to present assessment data in a way that is understandable to relevant parties. In the funding context, this means translating behavioral data into language that authorization reviewers can interpret and use to make informed decisions. Technical jargon that obscures rather than clarifies the clinical picture works against the client's interest.

Code 2.10 (Documenting Professional Work) takes on particular importance in funding contexts. Thorough documentation of treatment rationale, progress data, and clinical decision-making provides the evidentiary basis for authorization requests and appeals. Inadequate documentation is one of the most common reasons for authorization denials, and it is entirely within the behavior analyst's control to address.

Code 1.11 (Obtaining Informed Consent) is relevant when funding limitations affect the scope or intensity of treatment. Clients and caregivers have the right to know when authorized services fall short of what the behavior analyst considers clinically necessary, what options exist for addressing the shortfall, and what the potential consequences of reduced services may be. Transparent communication about funding limitations is an ethical obligation.

Code 2.16 (Describing Conditions for Successful Intervention) requires behavior analysts to identify the conditions necessary for treatment success. When a funding source's authorization does not provide these conditions, the behavior analyst must communicate this clearly, both to the payer and to the client.

The ethical tension between client advocacy and practical reality is most acute when all avenues of appeal have been exhausted and the authorization remains insufficient. In these situations, the behavior analyst must determine whether they can provide meaningful treatment within the authorized parameters, whether they should continue services at a reduced level rather than discontinue entirely, and how to minimize harm to the client. There is no easy formula for these decisions, but documenting the clinical reasoning behind them is essential for ethical accountability.

Assessment & Decision-Making

Effective engagement with funding sources requires a systematic approach to preparation, communication, and escalation.

Preparation begins with understanding the specific payer's requirements, processes, and decision-making criteria. Each insurance company, Medicaid program, and school district has its own authorization procedures, documentation requirements, and review standards. Investing time to understand these specifics prevents unnecessary denials caused by procedural errors rather than clinical disagreements.

Clinical documentation should be structured to anticipate and address payer concerns. Authorization requests should include clear operational definitions of target behaviors, quantitative baseline data, measurable treatment goals with defined criteria, a description of the evidence-based procedures to be used, the clinical rationale for the requested service intensity, and data demonstrating progress (or justifying continued treatment when progress is slow). Each element should be written in language accessible to a non-behavioral audience while maintaining clinical accuracy.

When an authorization is denied or reduced, the decision-making process follows a structured escalation path. First, review the denial to understand the stated reason. Is it a documentation issue, a clinical disagreement, or a policy limitation? Documentation issues can often be resolved by submitting additional information. Clinical disagreements may require a peer-to-peer review where the behavior analyst discusses the case directly with the payer's clinical reviewer. Policy limitations may require appeals that cite the payer's own published criteria, applicable regulations, or relevant clinical guidelines.

Peer-to-peer reviews are often the most effective avenue for resolving clinical disagreements because they allow direct communication between the behavior analyst and the payer's reviewer. Preparing for these conversations by organizing your clinical data, anticipating objections, and practicing your presentation improves the likelihood of a favorable outcome.

When internal appeals are unsuccessful, external appeal options may be available depending on the payer type and jurisdiction. State insurance departments, independent review organizations, and legal advocacy groups may provide additional avenues. Knowing these options and knowing when to escalate is part of the behavior analyst's professional competency in funding source engagement.

At the organizational level, tracking authorization outcomes, denial rates, and appeal success rates provides data for identifying systemic patterns. If a specific payer consistently denies a particular type of service, this data supports systemic advocacy efforts targeting that payer's policies.

What This Means for Your Practice

Whether you are a solo practitioner or part of a large organization, developing competency in funding source engagement is essential for your clients' access to appropriate services.

Invest in understanding the authorization processes of the payers you work with most frequently. Know their required documentation formats, their medical necessity criteria, their appeal timelines and procedures, and the names and roles of the clinical reviewers who make authorization decisions. This knowledge transforms you from a reactive recipient of authorization decisions to a proactive participant in the process.

Develop a documentation system that anticipates payer requirements from the start of treatment. If your initial assessment report, treatment plan, and progress notes consistently include the data elements that payers need for authorization decisions, the authorization process becomes an extension of your clinical documentation rather than a separate administrative burden.

When you receive a denial, treat it as the beginning of a process rather than a final decision. Most denials can be resolved through additional documentation, peer-to-peer review, or formal appeal. Track your appeal outcomes and refine your approach based on what works with each specific payer.

Build professional relationships with payer representatives when possible. Authorization reviewers are more likely to engage constructively with behavior analysts they know to be thorough, professional, and clinically competent. These relationships do not guarantee favorable decisions, but they create conditions for more productive dialogue when disagreements arise.

Advocate beyond individual cases. When you identify systemic payer practices that harm clients, share this information with professional organizations, advocacy groups, and colleagues. Individual case advocacy protects one client at a time; systemic advocacy can change the conditions for all clients served by that payer.